Targeting allosteric pockets of SARS-CoV-2 main protease M^pro

References

• Balasubramaniam, M., & Reis, R. J. S. (2020). Computational target-based drug repurposing of elbasvir, an antiviral drug predicted to bind multiple SARS-CoV-2 proteins. ChemRxiv.
   Google Scholar
• Binkowski, T. A., Naghibzadeh, S., & Liang, J. (2003). CASTp: Computed atlas of surface topography of proteins. Nucleic Acids Research, 31(13), 3352–3355. https://doi.org/10.1093/nar/gkg512
   PubMed Web of Science ®Google Scholar
• Brown, A. J., Won, J. J., Graham, R. L., Dinnon, K. H., Sims, A. C., Feng, J. Y., Cihlar, T., Denison, M. R., Baric, R. S., & Sheahan, T. P. (2019). Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase. Antiviral Research, 169, 104541 https://doi.org/10.1016/j.antiviral.2019.104541
   PubMed Web of Science ®Google Scholar
• Bzówka, M., Mitusińska, K., Raczyńska, A., Samol, A., Tuszyński, J. A., & Góra, A. (2020). Structural and Evolutionary Analysis Indicate That the SARS-CoV-2 Mpro Is a Challenging Target for Small-Molecule Inhibitor Design. International Journal of Molecular Sciences, 21(9), 3099. https://doi.org/10.3390/ijms21093099
   PubMed Web of Science ®Google Scholar
• Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Ruan, L., Song, B., Cai, Y., Wei, M., Li, X., Xia, J., Chen, N., Xiang, J., Yu, T., Bai, T., Xie, X., Zhang, L., Li, C., … Wang, C. (2020). A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19. New England Journal of Medicine, 382(19), 1787–1799.
   PubMed Web of Science ®Google Scholar
• Case, D. A., Ben-Shalom, I. Y., Brozell, S. R., Cerutti, D. S., Cheatham, T. E., Cruzeiro, V. W., Darden, T. A., Duke, R. E., Ghoreishi, D., Gilson, M. K., Gohlke, H., Goetz, A. W., Greene, D., Harris, R., Homeyer, N., Izadi, S., Kovalenko, A., Kurtzman, T., Lee, T. S., … Kollman, P. A. (2018). AMBER, University of California.
   Google Scholar
• Chen, H., Wei, P., Huang, C., Tan, L., Liu, Y., & Lai, L. (2006). Only one protomer is active in the dimer of SARS 3C-like proteinase. J Biol Chem, 281(20), 13894–13898. https://doi.org/10.1074/jbc.M510745200
   PubMed Web of Science ®Google Scholar
• Chen, H., Zhang, Z., Wang, L., Huang, Z., Gong, F., Li, X., & Chen, Y. (2020). First clinical study using HCV protease inhibitor danoprevir to treat naive and experienced COVID-19 patients. MedRxiv.
   Google Scholar
• Chu, C., Cheng, V., Hung, I., Wong, M., Chan, K., Chan, K., Kao, R. Y., Poon, L. L., Wong, C. L., Guan, Y., Peiris, J. S., Yuen, K. Y. & HKU/UCH SARS Study Group. (2004). Role of lopinavir/ritonavir in the treatment of SARS: Initial virological and clinical findings. Thorax, 59(3), 252–256. https://doi.org/10.1136/thorax.2003.012658
   PubMed Web of Science ®Google Scholar
• Darden, T., York, D., & Pedersen, L. (1993). Particle mesh Ewald: An N⋅ log (N) method for Ewald sums in large systems. The Journal of Chemical Physics, 98(12), 10089–10092. https://doi.org/10.1063/1.464397
   Web of Science ®Google Scholar
• Delano, W. L. (2002). PyMOL. DeLano Scientific.
   Google Scholar
• Dotolo, S., Marabotti, A., Facchiano, A., & Tagliaferri, R. (2020). A review on drug repurposing applicable to COVID-19. Briefings in Bioinformatics, https://doi.org/10.1093/bib/bbaa288
   Google Scholar
• El‐Baba, T. J., Lutomski, C. A., Kantsadi, A. L., Malla, T. R., John, T., Mikhailov, V., Bolla, J. R., Schofield, C. J., Zitzmann, N., Vakonakis, I., & Robinson, C. V. (2020). Allosteric Inhibition of the SARS‐CoV‐2 Main Protease: Insights from Mass Spectrometry Based Assays. Angewandte Chemie International Edition, 59(52), 23544-23548. https://doi.org/10.1002/anie.202010316
   Google Scholar
• Estrada, E. (2020). Topological analysis of SARS CoV-2 main protease<? A3B2 show [editpick]?>. Chaos: An Interdisciplinary Journal of Nonlinear Science, 30(6), 061102.
   PubMed Web of Science ®Google Scholar
• Fehr, A. R., & Perlman, S. (2015). Coronaviruses: an overview of their replication and pathogenesis Coronaviruses (pp. 1–23). Springer.
   Google Scholar
• Gaillard, T. (2018). Evaluation of AutoDock and AutoDock Vina on the CASF-2013 benchmark. Journal of Chemical Information and Modeling, 58(8), 1697–1706. https://doi.org/10.1021/acs.jcim.8b00312
   PubMed Web of Science ®Google Scholar
• Genheden, S., Kuhn, O., Mikulskis, P., Hoffmann, D., & Ryde, U. (2012). The normal-mode entropy in the MM/GBSA method: Effect of system truncation, buffer region, and dielectric constant. Journal of Chemical Information and Modeling, 52(8), 2079–2088. https://doi.org/10.1021/ci3001919
   PubMed Web of Science ®Google Scholar
• Ghebreyesus, T. A. (2020). WHO director-general's opening remarks at the media briefing on COVID-19. WHO.
   Google Scholar
• He, Y., Staschke, K. A., & Tan, S.-L. (2006). HCV NS5A: A multifunctional regulator of cellular pathways and virus replication. In Hepatitis C viruses: genomes and molecular biology. Horizon Bioscience.
   Google Scholar
• Huey, R., & Morris, G. M. (2008). Using AutoDock 4 with AutoDocktools: A tutorial (pp. 54–56). The Scripps Research Institute, USA.
   Google Scholar
• Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14(1), 33–38. https://doi.org/10.1016/0263-7855(96)00018-5
   PubMedGoogle Scholar
• Jakalian, A., Jack, D. B., & Bayly, C. I. (2002). Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation . Journal of Computational Chemistry, 23(16), 1623–1641. https://doi.org/10.1002/jcc.10128
   PubMed Web of Science ®Google Scholar
• Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., Peng, C., Duan, Y., Yu, J., Wang, L., Yang, K., Liu, F., Jiang, R., Yang, X., You, T., Liu, X., … Yang, H. (2020). Structure of M pro from SARS-CoV-2 and discovery of its inhibitors. Nature, 582(7811), 289–285. https://doi.org/10.1038/s41586-020-2223-y
   PubMed Web of Science ®Google Scholar
• Kneller, D. W., Phillips, G., O'Neill, H. M., Jedrzejczak, R., Stols, L., Langan, P., Joachimiak, A., Coates L., Kovalevsky, A. (2020). Structural Plasticity of the SARS-CoV-2 3CL Mpro Active Site Cavity Revealed by Room Temperature X-ray Crystallography
   Google Scholar
• Kumarasamy, N., Aga, E., Ribaudo, H. J., Wallis, C. L., Katzenstein, D. A., Stevens, W. S., Norton, M. R., Klingman, K. L., Hosseinipour, M. C., Crump, J. A. (2015). Lopinavir/ritonavir monotherapy as second-line antiretroviral treatment in resource-limited settings: Week 104 analysis of AIDS Clinical Trials Group (ACTG) A5230. Clinical Infectious Diseases, 60(10), 1552–1558.
   PubMed Web of Science ®Google Scholar
• Li, Y., Zhang, J., Wang, N., Li, H., Shi, Y., Guo, G., Liu, K., Zeng, H., Zou, Q. (2020). Therapeutic drugs targeting 2019-nCoV main protease by high-throughput screening. BioRxiv.
   Google Scholar
• Maier, J. A., Martinez, C., Kasavajhala, K., Wickstrom, L., Hauser, K. E., & Simmerling, C. (2015). ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB. Journal of Chemical Theory and Computation, 11(8), 3696–3713. https://doi.org/10.1021/acs.jctc.5b00255
   PubMed Web of Science ®Google Scholar
• Massova, I., & Kollman, P. A. (2000). Combined molecular mechanical and continuum solvent approach (MM-PBSA/GBSA) to predict ligand binding. Perspectives in Drug Discovery and Design, 18(1), 113–135. https://doi.org/10.1023/A:1008763014207
   Google Scholar
• McLeish, T. C., & Dubanevics, I. (2020). Computational Analysis of Dynamic Allostery and Control in the SARS CoV 2 Main Protease. bioRxiv,
   Google Scholar
• Miller, B. R., III, McGee, T. D., Jr, Swails, J. M., Homeyer, N., Gohlke, H., & Roitberg, A. E. (2012). MMPBSA.py: An Efficient Program for End-State Free Energy Calculations . Journal of Chemical Theory and Computation, 8(9), 3314–3321. https://doi.org/10.1021/ct300418h
   PubMed Web of Science ®Google Scholar
• O'Boyle, N. M., Banck, M., James, C. A., Morley, C., Vandermeersch, T., & Hutchison, G. R. (2011). Open Babel: An open chemical toolbox. Journal of Cheminformatics, 3(1), 33 https://doi.org/10.1186/1758-2946-3-33
   PubMed Web of Science ®Google Scholar
• Pence, H. E., & Williams, A. (2010). ChemSpider: an online chemical information resource. ACS Publications.
   Google Scholar
• Sanders, J. M., Monogue, M. L., Jodlowski, T. Z., & Cutrell, J. B. (2020). Pharmacologic treatments for coronavirus disease 2019 (COVID-19): A Review. JAMA, 323(18), 1824–1836. https://doi.org/10.1001/jama.2020.6019
   PubMed Web of Science ®Google Scholar
• Sencanski, M., Perovic, V., Pajovic, S., Adzic, M., Paessler, S., & Glisic, S. (2020). Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel in Silico Method. Molecules, 25(17), 3830. https://doi.org/10.3390/molecules25173830
   PubMed Web of Science ®Google Scholar
• Teague, S. J. (2003). Implications of protein flexibility for drug discovery. Nature Reviews. Drug Discovery, 2(7), 527–541. https://doi.org/10.1038/nrd1129
   PubMed Web of Science ®Google Scholar
• Ton, A. T., Gentile, F., Hsing, M., Ban, F., & Cherkasov, A. (2020). Rapid identification of potential inhibitors of SARS‐CoV‐2 main protease by deep docking of 1.3 billion compounds. Molecular Informatics, 39(8), 2000028. https://doi.org/10.1002/minf.202000028
   PubMed Web of Science ®Google Scholar
• Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455–461. https://doi.org/10.1002/jcc.21334
   PubMed Web of Science ®Google Scholar
• Ullrich, S., & Nitsche, C. (2020). The SARS-CoV-2 main protease as drug target. Bioorganic & Medicinal Chemistry Letters, 30(17), 127377
   PubMed Web of Science ®Google Scholar
• Van-Gunsteren, W. F., & Berendsen, H. J. C. (1977). Algorithms for Macromolecular Dynamics and Constraint Dynamics. Molecular Physics, 34(5), 1311–1327. https://doi.org/10.1080/00268977700102571
   Web of Science ®Google Scholar
• Wang, J., Wang, W., Kollman, P. A., & Case, D. A. (2006). Automatic atom type and bond type perception in molecular mechanical calculations. Journal of Molecular Graphics & Modelling, 25(2), 247–260. https://doi.org/10.1016/j.jmgm.2005.12.005
   PubMed Web of Science ®Google Scholar
• Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A., & Case, D. A. (2004). Development and testing of a general amber force field. Journal of Computational Chemistry, 25(9), 1157–1174. https://doi.org/10.1002/jcc.20035
   PubMed Web of Science ®Google Scholar
• Wishart, D. S., Knox, C., Guo, A. C., Shrivastava, S., Hassanali, M., Stothard, P., Chang, Z., & Woolsey, J. (2006). DrugBank: A comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Research, 34(Database issue), D668–D672. https://doi.org/10.1093/nar/gkj067
   PubMed Web of Science ®Google Scholar
• Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., Yuan, M.-L., Zhang, Y.-L., Dai, F.-H., Liu, Y., Wang, Q.-M., Zheng, J.-J., Xu, L., Holmes, E. C., & Zhang, Y.-Z. (2020). A new coronavirus associated with human respiratory disease in China. Nature, 579(7798), 265–269. https://doi.org/10.1038/s41586-020-2008-3
   PubMed Web of Science ®Google Scholar
• Xu, Z., Peng, C., Shi, Y., Zhu, Z., Mu, K., Wang, X., & Zhu, W. (2020). Nelfinavir was predicted to be a potential inhibitor of 2019-nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation. BioRxiv.
   Google Scholar
• Yao, T. T., Qian, J. D., Zhu, W. Y., Wang, Y., & Wang, G. Q. (2020). A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus-A possible reference for coronavirus disease-19 treatment option. Journal of Medical Virology, 92(6), 556–563. https://doi.org/10.1002/jmv.25729
   PubMed Web of Science ®Google Scholar
• Zhang, L., Lin, D., Sun, X., Curth, U., Drosten, C., Sauerhering, L., Becker, S., Rox, K., & Hilgenfeld, R. (2020). Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors. Science (New York, N.Y.), 368(6489), 409–412. https://doi.org/10.1126/science.abb3405
   PubMed Web of Science ®Google Scholar